Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes

Addictive Behaviors Reports

Volumn 8, Issue , 2018, Pages 102-106

  Cinnamon Bidwell, L ^a   YorkWilliams, Sophie L ^a   Mueller, Raeghan L ^a   Bryan, Angela D ^a   Hutchison, Kent E ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Abuse liability; CBD; Concentrated cannabis; Dabbing; Marijuana; THC

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ADULT; ANXIETY DISORDER; ARTICLE; CALIFORNIA; CANNABIS ADDICTION; CANNABIS SMOKING; CANNABIS USE; COLORADO; DISEASE SEVERITY; DRUG CONCENTRATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEVADA; OREGON; PRIORITY JOURNAL; SECONDARY ANALYSIS; WASHINGTON; WITHDRAWAL SYNDROME;

EID: 85052104043     PISSN: None     EISSN: 23528532     Source Type: Journal    
DOI: 10.1016/j.abrep.2018.08.004     Document Type: Article

References (13)

1. Bingham, R., The state of legal marijuana markets. Research, A.M., (eds.) Executive Summary, 5th ed., 2015.
2. Chan, G.C.K., Hall, W., Freeman, T.P., Ferris, J., Kelly, A.B., Winstock, A., User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. Drug and Alcohol Dependence 178 (2017), 32–38.
3. Daniulaityte, R., Lamy, F.R., Barratt, M., Nahhas, R.W., Martins, S.S., Boyer, E.W., Carlson, R.G., Characterizing marijuana concentrate users: A web-based survey. Drug and Alcohol Dependence 178 (2017), 399–407.
4. Koski, L., Kammerzell, R., Burack, J., Grotenhermen, F., Franson, K., Environment, C.D.o.P.H.a., (eds.) Marijuana equivalency in portion and dosage an assessment of physical and pharmacokinetic relationships in marijuana production and consumption in Colorado, 2015.
5. Loflin, M., Earleywine, M., A new method of cannabis ingestion: The dangers of dabs?. Addictive Behaviors 39 (2014), 1430–1433.
6. Meier, M.H., Associations between butane hash oil use and cannabis-related problems. Drug and Alcohol Dependence 179 (2017), 25–31.
7. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of Toxicological Sciences 40 (2015), 797–803.
8. Ranganathan, M., D'Souza, D.C., The acute effects of cannabinoids on memory in humans: A review. Psychopharmacology 188 (2006), 425–444.
9. Sagar, K.A., Lambros, A.M., Dahlgren, M.K., Smith, R.T., Gruber, S.A., Made from concentrate? A national web survey assessing dab use in the United States. Drug and Alcohol Dependence 190 (2018), 133–142.
10. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 59:Suppl. 20 (1998), 22–33.
11. Stogner, J.M., Miller, B.L., The dabbing dilemma: A call for research on butane hash oil and other alternate forms of cannabis use. Substance Abuse 36 (2015), 393–395.
12. Vandrey, R., Raber, J.C., Raber, M.E., Douglass, B., Miller, C., Bonn-Miller, M.O., Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA, 313(24), 2015, 2491.
13. Volkow, N.D., Compton, W.M., Weiss, S.R., Adverse health effects of marijuana use. The New England Journal of Medicine, 371, 2014, 879.